Top News

Brazil regulator says suspension of Sinovac COVID-19 vaccine was technical

FILE PHOTO: A display shows packages of vaccine candidate for SARS-CoV-2 by Sinovac Biotech during a government-organized media tour showcasing the company's development of a coronavirus disease (COVID-19) vaccine candidate in Beijing, China, September 24, 2020. REUTERS/Thomas Peter

BRASILIA (Reuters) - Brazil’s health regulator Anvisa said on Tuesday that its decision to suspend trials for China’s Sinovac COVID-19 vaccine was purely technical and dismissed any “politicization” of its work to ensure a safe and effective vaccine.

“We had no choice but to suspend the trials given the event,” the head of the agency Antônio Barra Torres said at a news conference. Reuters reported earlier on Tuesday, citing a source familiar with the matter, that the event was the suicide of a volunteer.

Reporting by Anthony Boadle; Editing by Chizu Nomiyama